Skin infection

 

Report Year

Trial Code

Trial Title

Clinicaltrials.gov

EudraCTno.

Source

2009

FUC 0301 INT

Fucidin® cream in the treatment of impetigo

NCT00986856

N/A

Summary

Report

Active Substance

fusidic acid

LEO Pharma Product

Fucidin®

Formulation

cream

Trial Phase

4

Population

children

2003

FCF 0001 INT

Fucicort®/Fucibet® fatty cream in clinically infected atopic dermatitis

N/A

N/A

Summary

Report

Active Substance

fucidic acid + betamethasone valerate

LEO Pharma Product

Fucicort® / Fucibet®

Formulation

cream & lipid cream

Trial Phase

3

Population

children

2002

FUH 9401 DK

Fucidin-H vs. hydrocortisone in atopic dermatitis

N/A

N/A

Summary

Report

Active Substance

fucidic acid + hydrocortisone acetate

LEO Pharma Product

Fucidin® H

Formulation

cream

Trial Phase

2

Population

children & dolescents

2002

FUS 9603 INT

Fucidin® b.i.d. low dose versus t.i.d. standard dose in children with skin and soft tissue infections

N/A

N/A

Summary

Report

Active Substance

fusidic acid

LEO Pharma Product

Fucidin®

Formulation

oral suspension

Trial Phase

3

Population

children

2000

FUT 9501 FR

Efficacy of a 7.5 days course of oral fusidic acid in the treatment of skin infections

N/A

N/A

Summary

Report

Active Substance

sodium fusidate

LEO Pharma Product

Fucidin®

Formulation

tablet

Trial Phase

3

Population

adults

1998

FUT 9404 INT

Fucidin® versus flucoxacillin in a skin and soft tissue infection

N/A

N/A

Summary

Report

Active Substance

sodium fusidate

LEO Pharma Product

Fucidin®

Formulation

tablet

Trial Phase

4

Population

adults

1997

FUT 9403 INT

Fucidin® versus flucoxacillin in a skin and soft tissue infection

N/A

N/A

Summary

Report

Active Substance

sodium fusidate

LEO Pharma Product

Fucidin®

Formulation

tablet

Trial Phase

4

Population

adults

1997

FUS 9601 UK

Pharmacokinetics of fusidic acid given in an oral suspension to children.

N/A

N/A

Summary

Report

Active Substance

fusidic acid

LEO Pharma Product

Fucidin®

Formulation

oral suspension

Trial Phase

1

Population

children

1997

FU 9204 UK/GP98

Comparative efficacy of low dose systemic Fucidin® 250 mg bd and Ciproxin® 250 mg bd in skin and soft tissue infection

N/A

N/A

Summary

Report

Active Substance

sodium fusidate

LEO Pharma Product

Fucidin®

Formulation

tablet

Trial Phase

4

Population

adults

1995

FU 9102 UK

Comparative efficacy of betamethasone / fusidic acid cream (Fucibet®) and betamethasone / clioquinol cream (Betnovate C® cream) in the treatment of infected or potentially infected eczema of the hands

N/A

N/A

Summary

Report

Active Substance

fusidic acid + betamethasone valerate

LEO Pharma Product

Fucicort® / Fucibet®

Formulation

lipid cream

Trial Phase

3

Population

adults

1995

FU 9202 DK

Comparative efficacy and resolution time of Fucicort® cream and Betnovate® cream in hand eczema of any kind

N/A

N/A

Summary

Report

Active Substance

fusidic acid + betamethasone valerate

LEO Pharma Product

Fucicort® / Fucibet®

Formulation

lipid cream

Trial Phase

4

Population

adults

1994

FU 9103 UK/GP93

Comparative effects of Fucidin® H cream (2% fusidic acid/1% hydrocortisone acetate) and Daktacort® cream (2% miconazole nitrate/1% hydrocortisone nitrate) in the treatment of clinically infected eczema.

N/A

N/A

Summary

Report

Active Substance

fucidic acid + hydrocortisone acetate

LEO Pharma Product

Fucidin® H

Formulation

cream

Trial Phase

3

Population

adults

1993

FUC 590 F

Comparative study Fucidin® film-coated tablets versus Pyostacine® in the treatment of skin infections

N/A

N/A

Summary

Reportin French Description: http://leo-pharma.com/Files/Billeder/flag_france_clinical_trials.png

Active Substance

sodium fusidate

LEO Pharma Product

Fucidin®

Formulation

tablet

Trial Phase

4

Population

adolescents & adults

1991

FU 990 F

Pharmacokinetics study of fusidic acid administered to children in a single dose of a banana-flavoured suspension

N/A

N/A

Summary

Report - in French Description: http://leo-pharma.com/Files/Billeder/flag_france_clinical_trials.png

Active Substance

fusidic acid

LEO Pharma Product

Fucidin®

Formulation

oral suspension

Trial Phase

2

Population

children

1990

GP 74

A comparison of fusidic acid cream (Fucidin cream) and mupirocin ointment (Bactroban) ointment in facial impetigo

N/A

N/A

Summary

Report

Active Substance

fusidic acid

LEO Pharma Product

Fucidin®

Formulation

cream

Trial Phase

4

Population

children, adolescents & adults

We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.